STUDENT SPOTLIGHT: Tim Lai, Auburn University

Tim Lai is a graduate student at the Auburn University Harrison College of Pharmacy’s Department of Health Outcomes Research and Policy, and the first recipient of the newly created fellowship for graduate students by the college and the Innovation and Value Initiative (IVI). Tim, thank you for taking the time to speak with us. Can […]

IVI and the Arthritis Foundation Recognize July as Juvenile Arthritis Awareness Month

We were so pleased to speak with Ms. Shannan O’Hara Levi about her experience growing up with juvenile arthritis. Listen as she offers an authentic perspective for people living with this serious health condition and highlights her advice to parents and caregivers. She also discusses some of the hidden costs of this illness. Shannan is […]

Moving Beyond Theory: The Need for Active Cultivation of the Value Flower

Despite decades of investment in patient-centered health care, we are all too aware that decisions about access and value are typically made in the context of financial risk management, and often without the input of those who should benefit from care. In addition to a myriad of payment reform strategies, rising interest in cost-effectiveness evaluation […]

IVI Co-Authored Paper Published in The Patient

IVI is pleased to share that a patient-centered impact paper, co-authored by IVI’s Jennifer Bright, was released this morning in The Patient – Patient-Centered Outcomes Research. The paper, “Patient-Centered Core Impact Sets – What They Are and Why We Need Them,” encourages thinking beyond traditional health outcomes when determining impact to include other equally (and sometimes […]

Heard on the Street at ISPOR

Last week, the IVI team traveled to the Washington, D.C. area for the 2022 ISPOR Annual Conference, and we were absolutely thrilled to see so many of you in person. It reminded us of the ‘why’ we do our work and how much we appreciate partnering with each of you. Even with the ongoing challenges […]

Measuring Value: COVID-19 Forces a Reassessment

Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 trillion dollars and with unemployment approaching 20%. In recent days, numerous articles have speculated on the pricing for Gilead’s new […]

Defining Value Starts with Patients

Authors: Alan Balch and Donna Cryer The vast majority of experts agree that we could, and should, be doing a lot more to include input from patients in value assessment, from conceptualization to data inputs to implementation. The crux of the problem is that in today’s world, we end up with models that assign a […]